Diet-associated vertically transferred metabolites and risk of asthma, allergy, eczema, and infections in early childhood

Research output: Contribution to journalJournal articleResearchpeer-review

Background: Evidence suggests maternal pregnancy dietary intake and nutrition in the early postnatal period to be of importance for the newborn child's health. However, studies investigating diet-related metabolites transferred from mother to child on disease risk in childhood are lacking. We sought to investigate the influence of vertically transferred metabolites on risk of atopic diseases and infections during preschool age. Methods: In the Danish population-based COPSAC2010 mother–child cohort, information on 10 diet-related vertically transferred metabolites from metabolomics profiles of dried blood spots (DBS) at age 2–3 days was analyzed in relation to the risk of childhood asthma, allergy, eczema, and infections using principal component and single metabolite analyses. Results: In 678 children with DBS measurements, a coffee-related metabolite profile reflected by principal component 1 was inversely associated with risk of asthma (odds ratio (95% CI) 0.78 (0.64; 0.95), p =.014) and eczema at age 6 years (0.79 (0.65; 0.97), p =.022). Furthermore, increasing stachydrine (fruit-related), 3-carboxy-4-methyl-5-propyl-2-furanpropanoate (fish-related), and ergothioneine (fruit-, green vegetables-, and fish-related) levels were all significantly associated with reduced risks of infections at age 0–3 years (p <.05). Conclusion: This study demonstrates associations between pregnancy diet-related vertically transferred metabolites measured in children in early life and risk of atopic diseases and infections in childhood. The specific metabolites associated with a reduced disease risk in children may contribute to the characterization of a healthy nutritional profile in pregnancy using a metabolomics-based unbiased tool for predicting childhood health.

Original languageEnglish
Article numbere13917
JournalPediatric Allergy and Immunology
Volume34
Issue number2
Number of pages8
ISSN0905-6157
DOIs
Publication statusPublished - 2023

Bibliographical note

Publisher Copyright:
© 2023 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

    Research areas

  • asthma, COPSAC, eczema, infections, metabolomics

ID: 358093886